XML 94 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2012
Text Block [Abstract]  
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2012:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance as of September 30, 2012
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$
—

 
$
25,429

 
$
—

 
$
25,429

U.S. agency debentures
 
—

 
2,936,150

 
—

 
2,936,150

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 
—

 
1,590,582

 
—

 
1,590,582

Agency-issued collateralized mortgage obligations - fixed rate
 
—

 
4,168,125

 
—

 
4,168,125

Agency-issued collateralized mortgage obligations - variable rate
 
—

 
1,939,799

 
—

 
1,939,799

Agency-issued commercial mortgage-backed securities
 
—

 
279,507

 
—

 
279,507

Municipal bonds and notes
 
—

 
100,221

 
—

 
100,221

Equity securities
 
7,917

 
—

 
—

 
7,917

Total available-for-sale securities
 
7,917

 
11,039,813

 
—

 
11,047,730

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
—

 
—

 
658,409

 
658,409

Other venture capital investments
 
—

 
—

 
118,622

 
118,622

Total non-marketable securities (fair value accounting)
 
—

 
—

 
777,031

 
777,031

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
3,807

 
1,609

 
—

 
5,416

Interest rate swaps
 
—

 
9,508

 
—

 
9,508

Foreign exchange forward and option contracts
 
—

 
13,116

 
—

 
13,116

Equity warrant assets
 
—

 
5,787

 
64,691

 
70,478

Loan conversion options
 
—

 
1,240

 
—

 
1,240

Client interest rate derivatives
 
—

 
236

 
—

 
236

Total assets (1)
 
$
11,724

 
$
11,071,309

 
$
841,722

 
$
11,924,755

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$
—

 
$
12,476

 
$
—

 
$
12,476

Client interest rate derivatives
 
—

 
247

 
—

 
247

Total liabilities
 
$
—

 
$
12,723

 
$
—

 
$
12,723

 
 
(1)
Included in Level 1, Level 2, and Level 3 assets are $3.4 million, $1.5 million, and $689.6 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2011:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance as of December 31, 2011
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$
—

 
$
25,964

 
$
—

 
$
25,964

U.S. agency debentures
 
—

 
2,874,932

 
—

 
2,874,932

Residential mortgage-backed securities:
 
 
 
 
 
 
 

Agency-issued mortgage-backed securities
 
—

 
1,564,286

 
—

 
1,564,286

Agency-issued collateralized mortgage obligations - fixed rate
 
—

 
3,373,760

 
—

 
3,373,760

Agency-issued collateralized mortgage obligations - variable rate
 
—

 
2,413,378

 
—

 
2,413,378

Agency-issued commercial mortgage-backed securities
 
—

 
178,693

 
—

 
178,693

Municipal bonds and notes
 
—

 
100,498

 
—

 
100,498

Equity securities
 
4,535

 
—

 
—

 
4,535

Total available-for-sale securities
 
4,535

 
10,531,511

 
—

 
10,536,046

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
—

 
—

 
611,824

 
611,824

Other venture capital investments
 
—

 
—

 
124,121

 
124,121

Other investments
 
—

 
—

 
987

 
987

Total non-marketable securities (fair value accounting)
 
—

 
—

 
736,932

 
736,932

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
1,410

 
—

 
—

 
1,410

Interest rate swaps
 
—

 
11,441

 
—

 
11,441

Foreign exchange forward and option contracts
 
—

 
18,326

 
—

 
18,326

Equity warrant assets
 
—

 
3,923

 
63,030

 
66,953

Loan conversion options
 
—

 
923

 
—

 
923

Client interest rate derivatives
 
—

 
50

 
—

 
50

Total assets (1)
 
$
5,945

 
$
10,566,174

 
$
799,962


$
11,372,081

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$
—

 
$
16,816

 
$
—

 
$
16,816

Client interest rate derivatives
 
—

 
52

 
—

 
52

Total liabilities
 
$
—

 
$
16,868

 
$
—

 
$
16,868

 
 
(1)
Included in Level 1 and Level 3 assets are $1.2 million and $647.5 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.

Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis
The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2012 and 2011, respectively:
(Dollars in thousands)
 
Beginning
Balance
 
Total Realized and Unrealized Gains (Losses) Included in Income
 
Purchases  
 
Sales
 
Issuances  
 
Distributions and Other Settlements
 
Transfers Into Level 3 
 
Transfers Out of Level 3
 
Ending
Balance
Three months ended September 30, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
639,596

 
$
12,104

 
$
35,092

 
$
—

 
$
—

 
$
(28,383
)
 
$
—

 
$
—

 
$
658,409

Other venture capital investments
 
120,111

 
3,259

 
953

 
(5,202
)
 
—

 
479

 
—

 
(978
)
 
118,622

Total non-marketable securities (fair value accounting) (1)
 
759,707

 
15,363

 
36,045

 
(5,202
)
 
—

 
(27,904
)
 
—

 
(978
)
 
777,031

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
68,619

 
(800
)
 
—

 
(5,954
)
 
2,994

 
—

 
—

 
(168
)
 
64,691

Total assets
 
$
828,326

 
$
14,563

 
$
36,045

 
$
(11,156
)
 
$
2,994

 
$
(27,904
)
 
$
—

 
$
(1,146
)
 
$
841,722

Three months ended September 30, 2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
515,118

 
$
32,041

 
$
42,590

 
$
—

 
$
—

 
$
(11,623
)
 
$
—

 
$
—

 
$
578,126

Other venture capital investments
 
114,070

 
17,237

 
2,193

 
(9,335
)
 
—

 
(4,005
)
 
—

 
—

 
120,160

Other investments
 
995

 
(16
)
 
—

 
—

 
—

 
(6
)
 
—

 
—

 
973

Total non-marketable securities (fair value accounting) (1)
 
630,183

 
49,262

 
44,783

 
(9,335
)
 
—

 
(15,634
)
 
—

 
—

 
699,259

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
49,777

 
8,192

 
—

 
(6,427
)
 
2,876

 
—

 
—

 
—

 
54,418

Total assets
 
$
679,960

 
$
57,454

 
$
44,783

 
$
(15,762
)
 
$
2,876

 
$
(15,634
)
 
$
—

 
$
—

 
$
753,677

Nine months ended September 30, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
611,824

 
$
38,765

 
$
90,173

 
$
—

 
$
—

 
$
(82,353
)
 
$
—

 
$
—

 
$
658,409

Other venture capital investments
 
124,121

 
(3,868
)
 
8,888

 
(9,441
)
 
—

 
495

 
—

 
(1,573
)
 
118,622

Other investments
 
987

 
21

 
—

 
—

 
—

 
(1,008
)
 
—

 
—

 
—

Total non-marketable securities (fair value accounting) (1)
 
736,932

 
34,918

 
99,061

 
(9,441
)
 
—

 
(82,866
)
 
—

 
(1,573
)
 
777,031

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
63,030

 
8,848

 
—

 
(15,672
)
 
9,167

 
1

 
—

 
(683
)
 
64,691

Total assets
 
$
799,962

 
$
43,766

 
$
99,061

 
$
(25,113
)
 
$
9,167

 
$
(82,865
)
 
$
—

 
$
(2,256
)
 
$
841,722

Nine months ended September 30, 2011
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
391,247

 
$
108,032

 
$
119,990

 
$
—

 
$
—

 
$
(41,143
)
 
$
—

 
$
—

 
$
578,126

Other venture capital investments
 
111,843

 
22,608

 
12,939

 
(27,513
)
 
—

 
283

 
—

 
—

 
120,160

Other investments
 
981

 
4

 
—

 
—

 
—

 
(12
)
 
—

 
—

 
973

Total non-marketable securities (fair value accounting) (1)
 
504,071

 
130,644

 
132,929

 
(27,513
)
 
—

 
(40,872
)
 
—

 
—

 
699,259

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
43,537

 
21,403

 
—

 
(19,889
)
 
10,058

 
(63
)
 
—

 
(628
)
 
54,418

Total assets
 
$
547,608

 
$
152,047

 
$
132,929

 
$
(47,402
)
 
$
10,058

 
$
(40,935
)
 
$
—

 
$
(628
)
 
$
753,677

 
 
(1)
Realized and unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(2)
Realized and unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held
The following table presents the amount of unrealized gains (losses) included in earnings (which is inclusive of noncontrolling interest) attributable to Level 3 assets still held at September 30, 2012:
 
 
Three months ended September 30, 2012
 
Nine months ended September 30, 2012
Non-marketable securities (fair value accounting):
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
12,724

 
$
38,916

Other venture capital investments
 
(963
)
 
4,177

Total non-marketable securities (fair value accounting) (2)
 
11,761

 
43,093

Other assets:
 
 
 
 
Equity warrant assets (3)
 
(2,480
)
 
(2,505
)
Total unrealized gains
 
$
9,281

 
$
40,588

Unrealized gains attributable to noncontrolling interests (1)
 
$
9,543

 
$
37,445

 
(1)
In the third quarter of 2012, for purposes of this disclosure we have revised our methodology to exclude reclassifications of previously recorded unrealized gains (losses) as a result of distributions.
(2)
Unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(3)
Unrealized (losses) gains are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs
The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2012. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.
(Dollars in thousands)
 
Fair value at September 30, 2012
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted 
Average
Other venture capital investments (fair value accounting)
 
$
118,622

 
Private company equity pricing
 
(1)
 
(1)
Equity warrant assets (private portfolio)
 
64,691

 
Modifed Black-Scholes option pricing model
 
Volatility
 
49.8
%
 
 
 
 
 
Risk-Free interest rate
 
0.3
%
 
 
 
 
 
Marketability discount (2)
 
22.5
%
 
 
 
 
 
Remaining life assumption (3)
 
45.0
%
 
 
 
(1)
In determining the fair value of our other venture capital investment portfolio, we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
(2)
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based on long-run averages and is influenced over time by various factors, including market conditions. On a quarterly basis, a sensitivity analysis is performed on our marketability discount. In the third quarter of 2012, we increased the marketability discount from 15.0 percent to 22.5 percent to reflect market conditions and trends.
(3)
We adjust the contractual remaining term of private company warrants based on our best estimate of the actual remaining life, which we determine by utilizing historical data on cancellations and exercises. At September 30, 2012, the weighted average contractual remaining term was 6.6 years, compared to our estimated remaining life of 3.0 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value
The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2012 and December 31, 2011:
 
 
 
 
Estimated Fair Value
(Dollars in thousands)
 
Carrying Amount
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
September 30, 2012:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
906,680

 
$
906,680

 
$
—

 
$
—

Non-marketable securities (cost and equity method accounting)
 
386,784

 
—

 
—

 
421,123

Net commercial loans
 
7,345,239

 
—

 
—

 
7,542,349

Net consumer loans
 
745,606

 
—

 
—

 
766,903

FHLB and FRB stock
 
39,301

 
—

 
—

 
39,301

Accrued interest receivable
 
62,441

 
—

 
62,441

 
—

Financial liabilities:
 
 
 
 
 
 
 
 
Short-term FHLB advances
 
215,000

 
215,000

 
—

 
—

Federal funds purchased
 
287,000

 
287,000

 
—

 
—

Other short-term borrowings
 
6,170

 
6,170

 
—

 
—

Non-maturity deposits (1)
 
17,575,816

 
17,575,816

 
—

 
—

Time deposits
 
149,250

 
—

 
149,031

 
—

5.375% Senior Notes
 
347,944

 
—

 
398,220

 
—

6.05% Subordinated Notes (2)
 
55,130

 
—

 
62,486

 
—

7.0% Junior Subordinated Debentures
 
55,240

 
—

 
52,268

 
—

Accrued interest payable
 
1,938

 
—

 
1,938

 
—

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 
—

 
—

 
—

 
21,467

December 31, 2011:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,114,948

 
$
1,114,948

 
$
—

 
$
—

Non-marketable securities (cost and equity method accounting)
 
267,508

 
—

 
—

 
290,393

Net commercial loans
 
6,192,578

 
—

 
—

 
6,336,705

Net consumer loans
 
687,557

 
—

 
—

 
627,733

FHLB and FRB stock
 
39,189

 
—

 
—

 
39,189

Accrued interest receivable
 
58,108

 
—

 
58,108

 
—

Financial liabilities:
 
 
 
 
 
 
 
 
Non-maturity deposits (1)
 
16,553,787

 
16,553,787

 
—

 
—

Time deposits
 
155,749

 
—

 
155,346

 
—

5.375% Senior Notes
 
347,793

 
—

 
362,786

 
—

6.05% Subordinated Notes (2)
 
55,075

 
—

 
57,746

 
—

5.70% Senior Notes (3)
 
143,969

 
—

 
145,184

 
—

7.0% Junior Subordinated Debentures
 
55,372

 
—

 
51,526

 
—

Other long-term debt
 
1,439

 
—

 
—

 
1,439

Accrued interest payable
 
6,689

 
—

 
6,689

 
—

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 
—

 
—

 
—

 
21,232

 
 
(1)
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
(2)
At September 30, 2012 and December 31, 2011, included in the carrying value and estimated fair value of our 6.05% Subordinated Notes was $9.5 million and $8.8 million, respectively, related to the fair value of the interest rate swap associated with the notes.
(3)
At December 31, 2011, included in the carrying value and estimated fair value of our 5.70% Senior Notes was $2.6 million related to the fair value of the interest rate swap associated with the notes.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2012:
(Dollars in thousands)
 
Carrying Amount      
 
Fair Value        
 
Unfunded
Commitments      
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
658,409

 
$
658,409

 
$
430,798

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Other investments (2)
 
54,288

 
55,715

 
6,750

Non-marketable securities (cost method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (3)
 
158,275

 
190,033

 
60,809

Total
 
$
870,972

 
$
904,157

 
$
498,357

 
 
(1)
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds, one of our direct venture funds and one other private equity fund. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life sciences companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $581.9 million and $420.0 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2)
Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds.
(3)
Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of the terms of the funds.